Cargando…
Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial
BACKGROUNDS: Urokinase (UK) 2 200 U/kg·h for 12 hours infusion(UK-12 h)is an ACCP recommended regimen in treating acute pulmonary embolism (PE). It is unclear whether this dose and time can be reduced further. We compared the efficacy and safety of 20, 000 U/kg for 2 hours (UK-2 h) with the UK-12 h...
Autores principales: | Wang, Chen, Zhai, Zhenguo, Yang, Yuanhua, Yuan, Yadong, Cheng, Zhaozhong, Liang, Lirong, Dai, Huaping, Huang, Kewu, Lu, Weixuan, Zhang, Zhonghe, Cheng, Xiansheng, Shen, Ying H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806365/ https://www.ncbi.nlm.nih.gov/pubmed/20040086 http://dx.doi.org/10.1186/1465-9921-10-128 |
Ejemplares similares
-
Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute Pulmonary Thromboembolism: A Randomized, Multicenter, Controlled Trial
por: Wang, Chen, et al.
Publicado: (2010) -
Efficacy and Safety of Bronchial Artery Embolization on Hemoptysis in Chronic Thromboembolic Pulmonary Hypertension: A Pilot Prospective Cohort Study
por: Yang, Suqiao, et al.
Publicado: (2019) -
Pulmonary Embolism Incidence and Fatality Trends in Chinese Hospitals from 1997 to 2008: A Multicenter Registration Study
por: Yang, Yuanhua, et al.
Publicado: (2011) -
Comparison of urokinase and reteplase thrombolytic treatment in patients with high-risk pulmonary embolism
por: Zhang, Yi, et al.
Publicado: (2019) -
Clinical Phenotypes With Prognostic Implications in Pulmonary Embolism Patients With Syncope
por: Zhang, Shuai, et al.
Publicado: (2022)